Vaerlose, Denmark

Lene Raunkjær Petersen

This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Calithera Biosciences, Inc.. Active years: 2019-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lene Raunkjær Petersen. Retrieved from https://idiyas.com/inventor/lene-raunkjær-petersen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

 

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Exploring the Innovative Work of Inventor Lene Raunkjær Petersen

Introduction

Lene Raunkjær Petersen, an esteemed inventor based in Værløse, Denmark, has made significant contributions to the field of biotechnology through his innovative work. With a total of three patents to his name, Petersen is recognized for his groundbreaking research in developing new therapeutic methods aimed at combating cancer.

Latest Patents

Petersen's latest patents focus on compositions and methods for inhibiting arginase activity. This disclosure details a novel class of compounds that possess inhibitory activity toward arginase. Furthermore, it encompasses pharmaceutical compositions comprising these compounds, along with methods for treating cancer using the arginase inhibitors detailed in the patent.

Career Highlights

Currently, Lene Raunkjær Petersen is associated with Calithera Biosciences, Inc., a company renowned for its dedication to pioneering cancer therapies. His expertise and innovative approach have played a pivotal role in the advancement of new treatment strategies in the field of oncology.

Collaborations

Throughout his career, Petersen has collaborated with notable colleagues such as Eric Brian Sjogren and Jim W Li. These collaborations have not only enriched his professional journey but have also contributed to the development of impactful scientific advancements in cancer treatment.

Conclusion

Lene Raunkjær Petersen exemplifies the spirit of innovation as an inventor dedicated to improving medical outcomes. His work in developing arginase inhibitors signifies a promising avenue in cancer therapeutics, illustrating the importance of research and collaboration in the quest for medical breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…